Similar results were obtained with plasmacytoid DC following maturation with influenza virus.

These results encourage continued efforts toward development of live influenza virus vaccines.

We are reminded each year to get vaccinated against the influenza virus.

Recently, the inhibition of OX40 has proved beneficial during influenza virus infection.

Both humoral and cellular immunity play important roles against influenza virus infection.

These results suggested the involvement of PKR in influenza virus-induced cell death.

Second, we discuss the status of currently licensed influenza virus vaccines.

Verdinexor blocks progeny influenza virus genome nuclear export, thus effectively inhibiting virus replication.

Thus, puerarin has potential utility for the treatment of the influenza virus infection.

In the present study, we used virosomes derived from influenza virus.

Cellular proteins that support influenza virus infection represent potential therapeutic targets.

Different amino acid sequences of influenza virus proteins contribute to different viral phenotypes.

Innate cytokine response provides the first line of defense against influenza virus infection.

To develop alternative antiviral agents against influenza virus infection is significant and urgent.

We first tested the effects of influenza virus on B cells in vitro.

The influenza virus infection prevalence increased after the laying phase among layer flocks.